You just read:

Ezetimibe/simvastatin used in a fixed-dose combination Significantly Reduced Cardiovascular Events More than Simvastatin Alone in Patients Presenting with Acute Coronary Syndromes in the Investigational IMPROVE-IT Study

News provided by

Merck Canada Inc.

Nov 19, 2014, 11:15 ET